246 related articles for article (PubMed ID: 23043046)
1. Neointimal tissue healing patterns after paclitaxel-eluting balloon treatment of in-stent restenosis: optical coherence tomography and intravascular ultrasound insights.
Sandoval J; Medina M; Alfonso F
J Invasive Cardiol; 2012 Oct; 24(10):E215-8. PubMed ID: 23043046
[TBL] [Abstract][Full Text] [Related]
2. Effect of drug-coated balloon on stent restenosis, neointimal proliferation, and coronary dissection: an optical coherence tomography analysis.
Fukushima T; Ashikaga T; Yoshikawa S; Hatano Y; Ueshima D; Yamamoto T; Yasuhiro M; Isobe M
Coron Artery Dis; 2018 Jan; 29(1):39-45. PubMed ID: 28902718
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study.
Fischer D; Scheller B; Schäfer A; Klein G; Böhm M; Clever Y; Cremers B
EuroIntervention; 2012 Aug; 8(4):450-5. PubMed ID: 22917728
[TBL] [Abstract][Full Text] [Related]
4. Differences in optical coherence tomographic findings and clinical outcomes between excimer laser and cutting balloon angioplasty for focal in-stent restenosis lesions.
Nishino M; Lee Y; Nakamura D; Yoshimura T; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y
J Invasive Cardiol; 2012 Oct; 24(10):478-83. PubMed ID: 23043029
[TBL] [Abstract][Full Text] [Related]
5. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.
Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR
Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536
[TBL] [Abstract][Full Text] [Related]
6. Differences in tissue characterization of restenotic neointima between sirolimus-eluting stent and bare-metal stent: integrated backscatter intravascular ultrasound analysis for in-stent restenosis.
Ando H; Amano T; Takashima H; Harada K; Kitagawa K; Suzuki A; Kunimura A; Shimbo Y; Harada K; Yoshida T; Kato B; Uetani T; Kato M; Matsubara T; Kumagai S; Yoshikawa D; Isobe S; Ishii H; Murohara T
Eur Heart J Cardiovasc Imaging; 2013 Oct; 14(10):996-1001. PubMed ID: 23341147
[TBL] [Abstract][Full Text] [Related]
7. Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study.
Adriaenssens T; Dens J; Ughi G; Coosemans M; Onsea K; Dubois C; Sinnaeve P; Vrolix M; Desmet W
EuroIntervention; 2011 May; 7 Suppl K():K100-5. PubMed ID: 22027717
[TBL] [Abstract][Full Text] [Related]
8. Optical coherence tomography study of healing characteristics of paclitaxel-eluting balloons vs. everolimus-eluting stents for in-stent restenosis: the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) randomised clinical trial.
Adriaenssens T; Dens J; Ughi G; Bennett J; Dubois C; Sinnaeve P; Wiyono S; Coosemans M; Belmans A; D'hooge J; Vrolix M; Desmet W
EuroIntervention; 2014 Aug; 10(4):439-48. PubMed ID: 25138182
[TBL] [Abstract][Full Text] [Related]
9. Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial.
Liistro F; Porto I; Angioli P; Grotti S; Ducci K; Falsini G; Bolognese L
Am Heart J; 2013 Nov; 166(5):920-6. PubMed ID: 24176449
[TBL] [Abstract][Full Text] [Related]
10. Association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervention for in-stent restenosis lesions: a comparison between balloon angioplasty, paclitaxel-coated balloon dilatation, and drug-eluting stent implantation.
Tada T; Kadota K; Hosogi S; Miyake K; Ohya M; Amano H; Izawa Y; Kanazawa T; Kubo S; Ichinohe T; Hyoudou Y; Hayakawa Y; Sabbah MM; Otsuru S; Hasegawa D; Habara S; Tanaka H; Fuku Y; Katoh H; Goto T; Mitsudo K
Eur Heart J Cardiovasc Imaging; 2015 Oct; 16(10):1101-11. PubMed ID: 25762559
[TBL] [Abstract][Full Text] [Related]
11. The role of integrated backscatter intravascular ultrasound in characterizing bare metal and drug-eluting stent restenotic neointima as compared to optical coherence tomography.
Sato K; Costopoulos C; Takebayashi H; Naganuma T; Miyazaki T; Goto K; Yamane H; Hagikura A; Kikuta Y; Taniguchi M; Hiramatsu S; Ito H; Colombo A; Haruta S
J Cardiol; 2014 Dec; 64(6):488-95. PubMed ID: 24794757
[TBL] [Abstract][Full Text] [Related]
12. Serial morphological and functional assessment of drug-eluting balloon for in-stent restenotic lesions: mechanisms of action evaluated with angiography, optical coherence tomography, and fractional flow reserve.
Agostoni P; Belkacemi A; Voskuil M; Nathoe HM; Doevendans PA; Stella PR
JACC Cardiovasc Interv; 2013 Jun; 6(6):569-76. PubMed ID: 23683736
[TBL] [Abstract][Full Text] [Related]
13. Simple balloon dilation for drug-eluting in-stent restenosis: an optical coherent tomography analysis.
Arikawa R; Yamaguchi H; Takaoka J; Miyamura A; Atsuchi N; Ninomiya T; Atsuchi Y; Ohishi M; Terashima M; Kaneda H
Cardiovasc Revasc Med; 2015; 16(1):27-31. PubMed ID: 25578507
[TBL] [Abstract][Full Text] [Related]
14. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
[TBL] [Abstract][Full Text] [Related]
15. Association between tissue characteristics evaluated with optical coherence tomography and mid-term results after paclitaxel-coated balloon dilatation for in-stent restenosis lesions: a comparison with plain old balloon angioplasty.
Tada T; Kadota K; Hosogi S; Miyake K; Amano H; Nakamura M; Izawa Y; Kubo S; Ichinohe T; Hyoudou Y; Eguchi H; Hayakawa Y; Otsuru S; Hasegawa D; Shigemoto Y; Habara S; Tanaka H; Fuku Y; Kato H; Goto T; Mitsudo K
Eur Heart J Cardiovasc Imaging; 2014 Mar; 15(3):307-15. PubMed ID: 24042176
[TBL] [Abstract][Full Text] [Related]
16. In vivo comparison between optical coherence tomography and intravascular ultrasound for detecting small degrees of in-stent neointima after stent implantation.
Suzuki Y; Ikeno F; Koizumi T; Tio F; Yeung AC; Yock PG; Fitzgerald PJ; Fearon WF
JACC Cardiovasc Interv; 2008 Apr; 1(2):168-73. PubMed ID: 19463295
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of balloon angioplasty and repeat stenting in patients with drug-eluting in-stent restenosis.
Alfonso F; Sandoval J; Pérez-Vizcayno MJ; Cárdenas A; Gonzalo N; Jiménez-Quevedo P; Ibáñez B; Núñez-Gil I; Rivero F; Escaned J; Fernández-Ortíz A; Macaya C
Int J Cardiol; 2015 Jan; 178():213-20. PubMed ID: 25464257
[TBL] [Abstract][Full Text] [Related]
18. Impact of diabetes mellitus on vessel response in the drug-eluting stent era: pooled volumetric intravascular ultrasound analyses.
Sakata K; Waseda K; Kume T; Otake H; Nakatani D; Yock PG; Fitzgerald PJ; Honda Y
Circ Cardiovasc Interv; 2012 Dec; 5(6):763-71. PubMed ID: 23149332
[TBL] [Abstract][Full Text] [Related]
19. Detailed comparison of intra-stent conditions 12 months after implantation of everolimus-eluting stents in patients with ST-segment elevation myocardial infarction or stable angina pectoris.
Mizoguchi T; Sawada T; Shinke T; Yamada S; Okamoto H; Kim SS; Takarada A; Yasaka Y
Int J Cardiol; 2014 Feb; 171(2):224-30. PubMed ID: 24388538
[TBL] [Abstract][Full Text] [Related]
20. Cutting balloon combined with paclitaxel-eluting balloon for treatment of in-stent restenosis.
Kong J; Hou J; Ma L; Xing L; Jia H; Liu H; Zhang S; Yu B; Jang IK
Arch Cardiovasc Dis; 2013 Feb; 106(2):79-85. PubMed ID: 23527911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
